Uncomfortable in dogs: medicines most often reported

1,467 FDA reports in dogs mention uncomfortable. These are the medicines named most often in those reports.

Bedinvetmab (Librela)
183 0.9% of its reports
Gabapentin
157 1.7% of its reports
Fluralaner (Bravecto)
149 0.2% of its reports
Prednisone
110 1.2% of its reports
Afoxolaner (NexGard)
108 0.2% of its reports
Carprofen (Rimadyl)
101 0.2% of its reports
Melarsomine (Immiticide)
99 0.4% of its reports
Ivermectin + Pyrantel (Heartgard Plus)
94 0.1% of its reports
Oclacitinib (Apoquel)
85 0.3% of its reports
Maropitant (Cerenia)
84 0.7% of its reports
Grapiprant (Galliprant)
81 0.9% of its reports
Moxidectin (ProHeart 6)
67 0.1% of its reports
Pyrantel + Sarolaner (Simparica Trio)
64 0.1% of its reports
Tigilanol Tiglate
62 3.1% of its reports
Trilostane (Vetoryl)
61 0.5% of its reports
Milbemycin Oxime + Spinosad (Trifexis)
60 0.0% of its reports
Diphenhydramine
58 1.2% of its reports
Milbemycin Oxime + Praziquantel (Interceptor Plus)
58 0.2% of its reports
Bordetella Vaccine
57 0.6% of its reports
Leptospirosis Vaccine
55 0.7% of its reports
Lokivetmab (Cytopoint)
50 0.8% of its reports
Famotidine
46 1.7% of its reports
Rabies Vaccine
46 0.5% of its reports
Florfenicol + Mometasone + Terbinafine
45 1.3% of its reports
Sarolaner (Simparica)
45 0.3% of its reports
Dexamethasone
44 1.6% of its reports
Polysulfated Glycosaminoglycan
43 0.8% of its reports
Butorphanol
42 0.9% of its reports
Lotilaner (Credelio)
40 0.4% of its reports
Dexmedetomidine (Dexdomitor)
39 0.7% of its reports
Trazodone
37 1.5% of its reports
Buprenorphine
36 2.3% of its reports
Amoxicillin + Clavulanate (Clavamox)
34 0.6% of its reports
Metronidazole
31 1.0% of its reports
Doxycycline
28 0.7% of its reports
Atipamezole
26 1.0% of its reports
Tramadol
26 0.7% of its reports
Distemper-parvo Vaccine
26 0.4% of its reports
Enrofloxacin (Baytril)
25 0.7% of its reports
Pimobendan (Vetmedin)
24 0.4% of its reports
Cefpodoxime
21 0.5% of its reports
Afoxolaner + Moxidectin + Pyrantel (NexGard PLUS)
21 0.2% of its reports
Ilunocitinib (Zenrelia)
20 0.9% of its reports